| Particulars |
|
|
|
| Company Name
| Glenmark Pharmaceuticals Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
28.22 |
B.V. (₹) |
855.70 |
| Sales(₹ Cr.) |
8,440.10 |
NP (₹ Cr.) |
942.47 |
| NP Var% |
-47.00 |
Div% |
500.00 |
| CPS(₹) |
41.80 |
EPS (₹) |
33.40 |
| Traded Value(₹ Lakhs) |
493.61 |
52 Week High |
2,537.00 |
| 52 Week Low |
1,794.00 |
Price BSE |
2,517.00 |
| Price NSE |
2,515.00 |
Market Capital (₹ Cr.) |
71,047.24 |
| P/C Ratio |
60.30 |
P/E Ratio |
75.40 |
| Price Vs.BV |
2.94 |
|
| Latest Quarter |
| Year End |
202606 |
Sales (₹ Cr.) |
2,342.53 |
| NP(₹ Cr.) |
546.23 |
NP Var % |
-8.00 |
| Trailing Twelve Months |
| Year End |
202606 |
Sales |
8,273.06 |
| OPM |
35.69 |
NP |
1,895.02 |
| NP Var% |
-22.09 |
EPS |
51.73 |
| PE |
48.66 |
|
|